Next report date
Report period
Q2 2024
EPS estimate
−0.21EUR
Revenue estimate
281.30 KEUR
−1.485EUR
−23.82 MEUR
811.31 KEUR
15.70 M
About Mainz Biomed N.V.
Sector
Industry
CEO
Guido Baechler
Website
Headquarters
Mainz
Founded
2021
ISIN
NL0015000LC2
FIGI
BBG013CXKZ88
Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange MAINZ BIOMED N.V. EO 1 stocks are traded under the ticker 4TO.
MAINZ BIOMED N.V. EO 1 is going to release the next earnings report on Sep 4, 2024. Keep track of upcoming events with our Earnings Calendar.
4TO earnings for the last quarter are −0.24 EUR per share, whereas the estimation was −0.29 EUR resulting in a 14.74% surprise. The estimated earnings for the next quarter are −0.20 EUR per share. See more details about MAINZ BIOMED N.V. EO 1 earnings.
MAINZ BIOMED N.V. EO 1 revenue for the last quarter amounts to 181.20 K EUR despite the estimated figure of 229.52 K EUR. In the next quarter revenue is expected to reach 294.72 K EUR.
Yes, you can track MAINZ BIOMED N.V. EO 1 financials in yearly and quarterly reports right on TradingView.
4TO net income for the last quarter is −4.70 M EUR, while the quarter before that showed −5.96 M EUR of net income which accounts for 21.20% change. Track more MAINZ BIOMED N.V. EO 1 financial stats to get the full picture.
No, 4TO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 4TO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MAINZ BIOMED N.V. EO 1 stock right from TradingView charts — choose your broker and connect to your account.
We've gathered analysts' opinions on MAINZ BIOMED N.V. EO 1 future price: according to them, 4TO price has a max estimate of 1.88 EUR and a min estimate of 1.88 EUR. Read a more detailed MAINZ BIOMED N.V. EO 1 forecast: see what analysts think of MAINZ BIOMED N.V. EO 1 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MAINZ BIOMED N.V. EO 1 EBITDA is −23.09 M EUR, and current EBITDA margin is −2.86 K%. See more stats in MAINZ BIOMED N.V. EO 1 financial statements.